Last updated: February 25, 2026
What Are the Fundamental Patentability Criteria for Biopharmaceutical Inventions in Ukraine?
Ukraine’s patent law adheres to standards aligned with the European Patent Convention (EPC). To secure patent protection, biopharmaceutical inventions must demonstrate novelty, inventive step, and industrial applicability.
Novelty: An invention is considered novel if it is not part of the state of the art. Public disclosures prior to filing date—publications, presentations, or existing patents—void novelty. The Ukrainian Patent Office (Ukrpatent) treats prior disclosures worldwide as relevant.
Inventive Step: The invention must not be obvious to a person skilled in the field. For biopharmaceuticals, this involves demonstrating unexpected technical advantages over existing solutions.
Industrial Applicability: The invention must be capable of practical use, which in biopharmaceuticals includes possible production or medical application.
How Does Ukraine Approach Patentability of Biopharmaceuticals?
Biological Material: Ukraine permits patenting inventions that involve biological material, provided the material is sufficiently characterized and the invention is not solely directed at the biological material itself but includes an application or process.
Patentable Subject Matter: Processes for producing biopharmaceuticals, new uses of known compounds, and modifications of existing biopharmaceuticals are patentable if they meet the criteria. The law excludes naturally occurring substances, genetic sequences as isolated entities (unless modified), and methods of treatment from patentability unless they fulfill novelty and inventive step.
Exceptions and Limitations: The law excludes patents on methods of medical diagnosis and surgical methods. However, inventions related to pharmaceutical products and manufacturing processes are eligible.
Enforceability of Biopharmaceutical Patents in Ukraine
Patent Rights: Once granted, patents provide exclusive rights to prevent third-party manufacturing, use, or sale of the patented biopharmaceutical within Ukraine.
Challenges to Enforcement: The Ukrainian legal system recognizes patent rights, but enforcement faces hurdles such as lengthy court proceedings and limited judicial expertise on complex biopharmaceutical issues.
Border Measures: The law permits customs actions to suspend import/export of infringing biopharmaceuticals once enforcement proceedings are initiated.
Patent Term and Supplementary Protection
The patent protection period is 20 years from the filing date. Ukraine does not offer supplementary protection certificates (SPCs), limiting patent term extension for biopharmaceuticals.
Scope of Claims in Biopharmaceutical Patents
Claim Types:
-
Product Claims: Cover specific molecules, genetic sequences, or formulations.
-
Process Claims: Cover manufacturing methods or purification techniques.
-
Use Claims: Cover therapeutic indications or new methods of treatment integrated into product claims.
Claim Drafting Strategy:
- Be specific enough to withstand validity challenges but broad enough to prevent design-around.
- Include multiple dependent claims to cover alternative embodiments.
- Clarify the scope of biological sequences and chemical structures using detailed descriptions and drawings.
Claim Limitations:
- Claims cannot cover naturally occurring substances unless a modified or isolated form with new properties is claimed.
- Method-of-treatment claims are generally unpatentable unless linked with patentable products or processes.
Policy and Procedural Aspects
Application Process: Examinations are substantively based, with Ukrainian examiners assessing novelty, inventive step, and industrial applicability. The process typically takes 2-3 years.
Priority and International Filing: Ukraine recognizes priority requests under the Paris Convention. Patents filed through the Patent Cooperation Treaty (PCT) can enter national phase within 30 months.
Opposition Proceedings: Post-grant opposition is not available in Ukraine; challenges are made through litigation.
Comparative Analysis with EPC Standards
| Aspect |
Ukraine |
EPC Standards |
| Patent Term |
20 years |
20 years |
| Biological Material |
Patentable if characterized properly |
Similar in approach |
| Methods of Medical Treatment |
Not patentable |
Not patentable |
| Patentability of Use Claims |
Allowed, if tied to patentable product |
Allowed |
| Enforceability |
Patent rights via courts, customs |
Similar in scope |
Key Takeaways
- Ukraine’s patent system for biopharmaceuticals aligns with European conventions but emphasizes detailed application drafting.
- Biological materials are patentable if well characterized; naturally occurring substances are generally excluded unless modified.
- Enforcement relies on judicial actions and customs measures; patent validity is subject to opposition.
- Claims should balance specificity and breadth, with particular attention to biological sequences and formulations.
- Patent protection lasts 20 years; no SPC extensions exist for biopharmaceuticals.
FAQs
Q1. Can genes be patented in Ukraine?
Yes, if isolated and characterized with specific applications, but claims cannot cover mere genetic sequences without modification.
Q2. Is there provisional patent protection in Ukraine?
No, Ukraine does not recognize provisional patents; applications must be filed fully before any public disclosure.
Q3. Are method of treatment claims patentable?
No, methods of treatment are excluded from patentability under Ukrainian law.
Q4. How long does it take to get a patent granted?
Typically 2-3 years from filing due to examination processes.
Q5. Can international patents be validated in Ukraine?
Yes, through PCT national phase entry or direct filings, provided they meet Ukrainian patentability criteria.
References:
[1] Ukrainian Patent Law. (2022). Official Law on Patents for Inventions. Verkhovna Rada of Ukraine.
[2] European Patent Convention (EPC). (1973). European Patent Organisation.
[3] World Intellectual Property Organization. (2022). Guide to Patentability of Biotechnological Inventions in Ukraine.
